Navidea Biopharmaceuticals (FRA:NO1A) Operating Cash Flow per Share : €-0.13 (TTM As of Sep. 2023)

View and export this data going back to 2004. Start your Free Trial

What is Navidea Biopharmaceuticals Operating Cash Flow per Share?

Navidea Biopharmaceuticals's operating cash flow per share for the three months ended in Sep. 2023 was €-0.10. Navidea Biopharmaceuticals's operating cash flow per share for the trailing twelve months (TTM) ended in Sep. 2023 was €-0.13.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 23.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Navidea Biopharmaceuticals's Operating Cash Flow per Share or its related term are showing as below:

FRA:NO1A' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -129 Med: -7 Max: 78.1
Current: 23.5

During the past 13 years, Navidea Biopharmaceuticals's highest 3-Year average Operating Cash Flow per Share Growth Rate was 78.10% per year. The lowest was -129.00% per year. And the median was -7.00% per year.

FRA:NO1A's 3-Year OCF Growth Rate is ranked better than
72.66% of 1240 companies
in the Biotechnology industry
Industry Median: 3.5 vs FRA:NO1A: 23.50

Navidea Biopharmaceuticals Operating Cash Flow per Share Historical Data

The historical data trend for Navidea Biopharmaceuticals's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Navidea Biopharmaceuticals Operating Cash Flow per Share Chart

Navidea Biopharmaceuticals Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Operating Cash Flow per Share

Get a 7-Day Free Trial

0.44

-0.59

-0.28

-0.31

-0.28

Navidea Biopharmaceuticals Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Operating Cash Flow per Share	Get a 7-Day Free Trial															-0.06	-0.07	-0.05	0.09	-0.10

Competitive Comparison of Navidea Biopharmaceuticals's Operating Cash Flow per Share

For the Biotechnology subindustry, Navidea Biopharmaceuticals's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Navidea Biopharmaceuticals's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Navidea Biopharmaceuticals's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Navidea Biopharmaceuticals's Price-to-Operating-Cash-Flow falls into.

Navidea Biopharmaceuticals Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Navidea Biopharmaceuticals's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2022 is calculated as

Operating Cash Flow per Share (A: Dec. 2022 )	=	Cash Flow from Operations (A: Dec. 2022 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2022 )
	=	-8.484	/	30.902
	=	-0.27

Navidea Biopharmaceuticals's Operating Cash Flow per Share for the quarter that ended in Dec. 2022 is calculated as

Operating Cash Flow per Share (Q: Sep. 2023 )	=	Cash Flow from Operations (Q: Sep. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Sep. 2023 )
	=	-9.603	/	96.1494
	=	-0.10

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.13

Navidea Biopharmaceuticals Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Navidea Biopharmaceuticals's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Navidea Biopharmaceuticals (FRA:NO1A) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Navidea Biopharmaceuticals Inc (FRA:NO1A) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

NAVB:USA

Address

4995 Bradenton Avenue, Suite 240, Dublin, OH, USA, 43017-3552

Website

https://www.navidea.com

Navidea Biopharmaceuticals Inc is a biotechnology company specializied in precision medicine. Its products, precision immunodiagnostic agents and immunotherapeutic products are designed to assist in the identification of undetected diseases and to improve targeted treatment. The company's platform, known as Manocept technology, aims to develop next-generation targeted diagnostics and therapies for cancer, autoimmune conditions, and other inflammatory diseases. One of the company's products is Lymphoseek, a radioactive diagnostic agent indicated to locate lymph nodes.

Navidea Biopharmaceuticals (FRA:NO1A) Headlines

No Headlines